Evidence map›Paper›PMID 36468924›Full record

ArticleArchives of endocrinology and metabolism2023

Flash glucose monitoring system in patients with type 1 diabetes in healthcare center in Brazil: real world data from a short-term prospective study.

Alessandra S M Matheus, Juliana Brazil Fontes Pascoal, Carolina Alves Cabizuca, Lucianne Righeti Monteiro Tannus, Rafael Seno Guimarães, Diogo Menezes Ferrazani Mattos, Roberta Arnoldi Cobas

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Archives of endocrinology and metabolism, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Evaluation of Asymptomatic Fasting Hypoglycemia in Outpatients Without Diabetes.Journal of the American Board of Family Medicine : JABFM · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Alessandra S M MatheusDepartamento de Clínica Médica, Unidade de Diabetes, Hospital Universitário do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brasil, alessandramatheus79@yahoo.com.
Juliana Brazil Fontes PascoalDepartamento de Clínica Médica, Unidade de Diabetes, Hospital Universitário do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brasil.
Carolina Alves CabizucaDepartamento de Clínica Médica, Unidade de Diabetes, Hospital Universitário do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brasil.
Lucianne Righeti Monteiro TannusDepartamento de Clínica Médica, Unidade de Diabetes, Hospital Universitário do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brasil.
Rafael Seno GuimarãesCiências Médicas, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brasil.
Diogo Menezes Ferrazani MattosLabGen/MidiaCom, Programa de Pós-graduação em Engenharia Elétrica e de Telecomunicações, Departamento de Engenharia de Telecomunicações, Universidade Federal Fluminense, Niterói, RJ, Brasil.
Roberta Arnoldi CobasDepartamento de Clínica Médica, Unidade de Diabetes, Hospital Universitário do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brasil.
Universidade do Estado do Rio de Janeiro · BRUniversidade Federal Fluminense · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To evaluate the alternate use of flash glucose monitoring (FGM) with self-monitoring blood glucose (SMBG), in patients with type 1 diabetes (T1D). Materials and methods: Two weeks of open FGM (P2), both preceded (P1) and followed by 2 weeks (P3) of SMBG with a blinded FGM system. Mean absolute relative difference (MARD) was calculated by (|FGMi - SMBGi|) / SMBGi, where it was a paired data sample. Results: In total, 34 patients were evaluated. Time in range (TIR) did not change between P1 and P2. In 12 patients (35.3%), TIR increased from 40% at P1 to 52% at P2 ( Conclusion: FGM after usual SMBG decreased the % time spent in hypoglycemia concomitant with an undesired increase in % time spent in hyperglycemia. Lower accuracy of FGM regarding hypoglycemia levels could result in overcorrection of hypoglycemia.

Indexed as

Diabetes Mellitus, Type 1HyperglycemiaHypoglycemiaBlood GlucoseBlood Glucose Self-MonitoringBrazilDelivery of Health CareGlucoseHumansHypoglycemic AgentsProspective StudiesBlood GlucoseGlucoseHypoglycemic Agentscontinuous glucose monitoringFlash glucose monitoring systemFreeStyle Libreglycated hemoglobinglycemic controlhypoglycemiatime in range

Identifiers

PMID36468924
PMCPMC10247245
OpenAlexW4310700813

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.